Litcius/Paper detail

Safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial

Raquel González, Tacilta Nhampossa, Ghyslain Mombo‐Ngoma, Johannes Mischlinger, Meral Esen, André-Marie Tchouatieu, Anete Mendes, Antía Figueroa-Romero, Rella Zoleko‐Manego, Bertrand Lell, Heimo Lagler, Linda Stoeger, Lia Betty Dimessa, Myriam El Gaaloul, Sergi Sanz, Susana Méndez, Mireia Piqueras, Esperança Sevene, Michael Ramharter, Francisco Saúte, Clara Menéndez, Frédérique Mbang Abba, Marc Bañuls, Saskia Dede Davi, Wilfrid Ndzebe Ndoumba, Maura Mazuze, Ulysse Pascale Minkobame Zaga Minko, Clara Pons‐Duran, Arnau Vañó-Boira, Teodora Vaz

2024The Lancet Infectious Diseases24 citationsDOI

Topics & Concepts

MedicinePiperaquineMalariaPlaceboDouble blindHuman immunodeficiency virus (HIV)DihydroartemisininObstetricsPediatricsArtemisininAlternative medicinePlasmodium falciparumFamily medicineImmunologyPathologyMalaria Research and ControlParasites and Host InteractionsBiological Research and Disease Studies
Safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial | Litcius